Study details strategies to address barriers keeping older adults out of clinical trials

clinical trials
Credit: CC0 Public Domain

A City of Hope-led study revealed little effort has been made to improve older adult representation in clinical trials of new cancer drugs, even when the treatment is aimed at a disease that disproportionately affects this age group.

"There is currently no incentive to establish real-world effectiveness among older adults. Older adults need a seat at the table," said Mina Sedrak, M.D., M.S., lead author of the study and deputy director of the Center for Cancer and Aging at City of Hope, a world-renowned independent research and treatment center for , diabetes and other life-threatening diseases.

Two in 5 Americans with cancer are age 70 or older, yet fewer than 25% of patients in cancer registered with the Food and Drug Administration are in this age group, Sedrak said.

The study was published in the journal CA: A Cancer Journal for Clinicians on Oct. 1. Researchers reviewed 8,691 studies that evaluated barriers which hindered older adults from participating in cancer trials. Twelve articles defined complex, interrelated problems as root causes, including stringent eligibility criteria, physician concern for toxicity, ageism, transportation and caregiver burden.

Only one study implemented an intervention meant to increase enrollment of older adults in trials—and it was not successful. This finding starkly amplifies the lack of effective strategies to improve participation of this underrepresented group in cancer research.

The researchers report that cancer must ask appropriate questions tailored or driven by the needs of with cancer and should measure relevant outcomes. Their call to action applies to all oncologists and primary care providers, not just geriatric oncologists, Sedrak said, adding that patients should advocate for themselves.

"Ask your doctor about clinical trial opportunities when you're diagnosed with cancer and do your own research because there may be an option that you haven't heard about. It may benefit you, but perhaps your doctor may not have considered you for the investigational trial," he said.


Explore further

Study finds older persons underrepresented in COVID-19 treatment and vaccine trials

More information: Mina S. Sedrak et al. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA: A Cancer Journal for Clinicians First published: 01 October 2020 doi.org/10.3322/caac.21638
Citation: Study details strategies to address barriers keeping older adults out of clinical trials (2020, October 1) retrieved 1 December 2020 from https://medicalxpress.com/news/2020-10-strategies-barriers-older-adults-clinical.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments